National diagnostic and care protocols published by French HAS in the first half of 2020

17

Jul 2020

The French High Authority for Health (HAS) develops national diagnostic and care protocols whose objective is to guarantee the quality and safety of care delivery within the French setting. In the first half of 2020, national diagnostic and care protocols have been developed for the following eighteen topics:

  • Glanzmann's thrombasthenia and related platelet pathologies
  • 7q11.23 microduplication syndrome
  • MECP2 gene duplication syndrome
  • Behçet's disease
  • Becker's muscular dystrophy
  • Trisomy 21
  • Child hypersensitivity pneumonitis
  • Spinal dysraphism (Spina Bifida) - urological management in adults
  • HNF-1β related disease
  • Pulmonary arterial hypertension
  • Charcot-Marie-Tooth hereditary sensitive motoric neuropathies
  • Takayasu arteritis
  • Chronic non-infectious uveitis in children and adults
  • Allan Herndon-Dudley Syndrome (AHDS) (MCT8 thyroid hormone transporter)
  • Non-Vascular Ehlers-Danlos Syndrome (NVEDS)
  • Bullous pemphigoid
  • AA Amyloidosis
  • Generic Polyhandicap

See the report in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2023

On March 2, 2023, the decision of the National Union of Health Insurance Funds relating to the update of the CCAM Nomenclature of procedure codes was published in the Official Journal of the French Republic. Changes include registration of new procedure codes, modification and removal of some existing codes. Newly introduced codes concern cardiovascular procedures, interventional radiology, orthopedics, peripheral vascular procedures, and others.

Read more

22

Mar 2023

A new preeclampsia screening algorithm has been evaluated within the "New Method" framework since 2021. The algorithm helps to predict the risk of preeclampsia in the first trimester based on several parameters, including ultrasound examination and measurement of the Placenta Growth Factor (PIGF). In March 2023, the Decision Forum for "New Method" was held and commissioned to perform the implementation study of a new screening algorithm at St. Olav's Hospital.

Read more

21

Mar 2023

On March 8, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the coverage of the INTERVAPOR system for lung volume reduction under Forfait innovation program.

Read more

20

Mar 2023

On March 1, 2023, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) updated three Articles of the Nomenclature related to in-vitro diagnostics. Twelve new codes concerning clinical biology, molecular biology for infections, and genetics were implemented.

Read more

10

Mar 2023

In February 2023, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (transvenous obliteration for gastric varices, biodegradable spacer to reduce rectal toxicity during radiotherapy for prostate cancer), one new Health Technology Evaluation (guided self-help digital cognitive behavioural therapy), and two new Medtech Innovation Briefings (LIVERFASt, and Ambu aScope 4 RhinoLaryngo). Also, one new clinical guideline was published, and one was updated.

Read more